CADENCE CAPITAL MANAGEMENT LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 158 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
CADENCE CAPITAL MANAGEMENT LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$681,000
+23.6%
35,820
-27.9%
0.04%
+41.9%
Q2 2015$551,000
-59.2%
49,707
-42.3%
0.03%
-62.2%
Q1 2015$1,350,000
+118.8%
86,080
+112.1%
0.08%
+127.8%
Q4 2014$617,00040,5800.04%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Rokos Capital Management LLP 6,474,348$11,394,8520.84%
WASATCH ADVISORS LP 13,642,417$24,010,6540.15%
Avidity Partners Management LP 2,470,000$4,347,2000.14%
Acrisure Capital Management, LLC 75,832$133,4640.14%
Golden State Equity Partners 135,765$238,9460.13%
Long Focus Capital Management, LLC 1,072,000$1,886,7200.11%
KLK CAPITAL MANAGEMENT LLC 44,323$78,0080.10%
CAXTON ASSOCIATES LP 288,218$507,2640.08%
XTX Topco Ltd 206,334$363,1480.08%
Rhenman & Partners Asset Management AB 314,157$534,0670.06%
View complete list of SANGAMO THERAPEUTICS INC shareholders